Covetrus, Inc.
CVET · NASDAQ
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $2 | $3 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $4 | $3 | $4 | $3 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 6% | 2.3% | -3.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 18.8% | 19.6% | 18.9% | 18.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 4.3% | 5.1% | 4.5% | 3.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -0.3% | -0.2% | -0.3% | -0.3% |
| EPS Diluted | -0.029 | -0.015 | -0.022 | -0.029 |
| % Growth | -97.2% | 33.2% | 25.7% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | $0 |